open access

Vol 48, No 5 (2016)
Letters to editor
Published online: 2016-11-06
Submitted: 2016-09-27
Accepted: 2016-10-28
Get Citation

Isolated lower limb gangrene: a caveat of terlipressin therapy

Ankur Khandelwal, Devendra Gupta, Rudrashish Haldar, Anindita Rai
DOI: 10.5603/AIT.a2016.0049
·
Pubmed: 27824220
·
Anaesthesiol Intensive Ther 2016;48(5):370-372.

open access

Vol 48, No 5 (2016)
Letters to editor
Published online: 2016-11-06
Submitted: 2016-09-27
Accepted: 2016-10-28

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

1014

About this article
Title

Isolated lower limb gangrene: a caveat of terlipressin therapy

Journal

Anaesthesiology Intensive Therapy

Issue

Vol 48, No 5 (2016)

Pages

370-372

Published online

2016-11-06

DOI

10.5603/AIT.a2016.0049

Pubmed

27824220

Bibliographic record

Anaesthesiol Intensive Ther 2016;48(5):370-372.

Keywords

1014

Authors

Ankur Khandelwal
Devendra Gupta
Rudrashish Haldar
Anindita Rai

References (11)
  1. Ozel Coskun BD, Karaman A, Gorkem H, et al. Terlipressin-induced ischemic skin necrosis: a rare association. Am J Case Rep. 2014; 15: 476–479.
  2. Ortega R, Ginès P, Uriz J, et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology. 2002; 36(4 Pt 1): 941–948.
  3. Le Moine O, el Nawar A, Jagodzinski R, et al. Treatment with terlipressin as a bridge to liver transplantation in a patient with hepatorenal syndrome. Acta Gastroenterol Belg. 1998; 61(2): 268–270.
  4. Lee HJu, Oh MJ. A case of peripheral gangrene and osteomyelitis secondary to terlipressin therapy in advanced liver disease. Clin Mol Hepatol. 2013; 19(2): 179–184.
  5. Yefet E, Gershovich M, Farber E, et al. Extensive epidermal necrosis due to terlipressin. Isr Med Assoc J. 2011; 13(3): 180–181.
  6. Halimi C, Bonnard P, Bernard B, et al. Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study. Eur J Gastroenterol Hepatol. 2002; 14(2): 153–158.
  7. Binanay C, Califf RM, Hasselblad V, et al. ESCAPE Investigators and ESCAPE Study Coordinators. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA. 2005; 294(13): 1625–1633.
  8. Kam PCA, Williams S, Yoong FFY. Vasopressin and terlipressin: pharmacology and its clinical relevance. Anaesthesia. 2004; 59(10): 993–1001.
  9. Sundriyal D, Kumar N, Patnaik I, et al. Terlipressin induced ischaemia of skin. BMJ Case Rep. 2013.
  10. Brodszky V, Farkas K, Járai Z, et al. [Effectiveness of prostanoids in patients with critical leg ischemia]. Orv Hetil. 2011; 152(51): 2047–2055.
  11. Yefet E, Gershovich M, Farber E, et al. Extensive epidermal necrosis due to terlipressin. Isr Med Assoc J. 2011; 13(3): 180–181.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

VM Media sp. z o.o. VM Group sp.k., Grupa Via Medica, Świętokrzyska 73 St., 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl